* Some show antimicrobial or other therapeutic properties, and they have a long history in the treatment of human diseases (5, 6). However, their use is considered to be “naturopathic” medicine, and to date, none have been approved by regulatory agencies for therapeutic applications.
* This deposit differs from other clays such as kaolinite or bentonite. X-ray diffraction shows that KC possesses a low clay mineral content (~24% [wt]), dominated by the presence of biotite (unpublished data). Moreover, as a natural clay deposit, KC has a significant resident microbial community (1,000 to 3,000 taxa), which includes Actinobacteria, which are known to make bioactive small molecules and may contribute to KC activity by the production of antimicrobials (unpublished data).
* More recently, the antibacterial activities and physicochemical characteristics of other therapeutic clay minerals have been investigated in the laboratory (11, 12). Haydel et al. reported on the broad-spectrum in vitro antibacterial activities of a natural iron-rich clay (CsAgO2) that was used to treat patients with Buruli ulcer (12).
* We suggest that the broad-spectrum antibacterial activity of KC may be a valuable option for the treatment of ESKAPE infections, especially in last-resort situations
Looks like they are saying this clay has some interesting physical, microbial, and mineral properties, in other words, it seems like they dont have any idea of why it works but are pretty sure it does.
Is this really true? That we don't know, or only have a very vague idea about the pharmacodynamics, or simply the mechanism of action of various treatments, so the process is more about establishing that they aren't harmful?
> The FDA does not actually require you to have a mechanism – that’s a common misconception. The FDA wants to see safety and efficacy. Now, a known mechanism will probably make the assessment of both those factors easier, to be sure, so all things being equal, you’d rather know how your drug works.
We know the basic mechanism of action behind SSRIs, but you'd be hard pressed to find anyone that can tell you definitively why they can be effective.
They are some of the most prescribed drugs in America. They have a better safety profile than MAOIs, despite that the latter can be more effective in treating depression / anxiety.
There was a theory behind why SSRIs work that existed when they were developed (the serotonin theory of depression), but this theory was later shown to be wrong - basically, SSRIs do modulate serotonin but that has no relation to whether you are depressed; if SSRIs do work, its through another mechanism. In addition the efficacy is greatly overstated; large follow-up studies have shown that they only have measurable effects on the most severely depressed individuals. The vast majority of people being prescribed SSRIs do not fall in this category and likely receive no benefit beyond placebo.
This, of course, highly depends on what your definition of "severely depressed" is. There are several standards whose ranges don't even overlap on the same scale. [1] Also consider that people who have moderate depression may have episodes that put them in the severe category, which we would like to treat effectively.
From what I've read about some medicines it's something like "We originally used it for this but it turns out it stops this too! (we're not entirely sure why)"
Off-label prescription is prescribing a drug for non-intended purpose.
Viagra for example, was originally studied for high blood pressure.
I've also seen a tv program where they visited a pharmacy company's lab that's literally machines mixing random drugs in order to find their next product. The place was the size of a walmart.
There are several treatments the working principles of which we have more or less no idea about.
The process is extracting active compounds, establishing that they do something (and if so what), finding out whether there are safe dosages, charting what these safe dosages are and looking for a way to mass-produce the compounds.
You may have heard that many medicines are found by testing untold number of Amazonian species for medicinal properties. That sort of search finds things that work, not the reasons why.
I've seen more than one prescription-drug commercial on TV that uses the fine print (sometimes even the voiceover!) to say "we don't know how or why this drug has the effects it does".
http://mbio.asm.org/content/7/1/e01842-15.full
* Some show antimicrobial or other therapeutic properties, and they have a long history in the treatment of human diseases (5, 6). However, their use is considered to be “naturopathic” medicine, and to date, none have been approved by regulatory agencies for therapeutic applications.
* This deposit differs from other clays such as kaolinite or bentonite. X-ray diffraction shows that KC possesses a low clay mineral content (~24% [wt]), dominated by the presence of biotite (unpublished data). Moreover, as a natural clay deposit, KC has a significant resident microbial community (1,000 to 3,000 taxa), which includes Actinobacteria, which are known to make bioactive small molecules and may contribute to KC activity by the production of antimicrobials (unpublished data).
* More recently, the antibacterial activities and physicochemical characteristics of other therapeutic clay minerals have been investigated in the laboratory (11, 12). Haydel et al. reported on the broad-spectrum in vitro antibacterial activities of a natural iron-rich clay (CsAgO2) that was used to treat patients with Buruli ulcer (12).
* We suggest that the broad-spectrum antibacterial activity of KC may be a valuable option for the treatment of ESKAPE infections, especially in last-resort situations
Looks like they are saying this clay has some interesting physical, microbial, and mineral properties, in other words, it seems like they dont have any idea of why it works but are pretty sure it does.